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ABSTRACT
This work aimed to develop a simple and rapid spectrophotometric method for the analysis of erythromycin in pharmaceutical dosage forms. Direct UV and first derivative measurements at the wavelengths of 285 and 300 nm, respectively, in combination with standard addition method gave promising results. In both techniques, methanol was used as a solvent and dibasic
potassium phosphate buffer (pH 8) was used to hydrolyze erythromycin stearate to erythromycin. Both the direct UV and first
derivative measurements using standard addition method illustrated excellent linearity in the concentration range of 3-15 mg/mL
(r 2 > 0.98 and > 0.99, respectively) with good precision (%RSD < 0.65%). The limits of detection (LOD) of direct UV and first
derivative measurements were 0.08 and 1.37 mg/mL, respectively, and the limits of quantitation (LOQ) were 0.24 and 4.17 mg/
mL, respectively. However, the first derivative measurement showed better % mean recovery (97.6% and 106.5% for brand A and
B, respectively, %RSD < 3.34%) than the direct UV measurement (66.03% and 43.80% for brand A and B, respectively, %RSD up
to 47.39%). Thus, the first derivative measurement using standard addition method was valuable for analyzing erythromycin in
dosage forms, which excipients strongly interfere the UV absorbance of the drug.
Key words: erythromycin, spectrophotometric method, direct UV measurement, first derivative measurement

INTRODUCTION
Er ythromycin, produced by Saccharopolyspora
erythreas (formerly known as Streptomyces erythraeus)(1), is a macrolide antibiotic consisting of a 14 member
ring, a ketone group, two glycosidic bonds and a dimethylamino group (Figure 1) (2-4). The drug targets at the
ribosome and inhibits the protein synthesis of Gram
positive bacteria such as Mycoplasma and Chlamydia (5-6). Erythromycin is used for treatment of several
infection diseases and in patients allergic to the penicillins. Erythromycin easily degrades in acidic conditions
giving inactive compounds, 8,9-anhydro-6,9-hemiketal
and erythromycin-6,9,12-spiroketal (7). To increase its
acid stability and bioavailability, erythromycin is available in several forms including estolate, ethysuccinate
and stearate.
Several methods have been proposed for the analysis
of erythromycin. Dehouck et al.(4) reported the HPLC
analysis of erythromycin and benzoylperoxide in acne gel
on a Xterra RP18 column using acetonitrile, 0.2 M dipotassium hydrogen phosphate and water (35:5:60, v/v) as a
mobile phase and a detection wavelength at 215 nm. Leal
et al.(8) analyzed erythromycin and other six macrolide
antibiotics by HPLC using a C18 column, a mobile phase
consisting of phosphate buffer (pH 2.5) and acetonitrile
* Author for correspondence. Tel: +662-644-8695;
Fax:+662-644-8695; E-mail: pylll@mahidol.ac.th

and monitored the wavelengths in a range of 204-287
nm. HPLC-MS (mass spectrometry) was also employed
for the analysis of seven macrolide antibiotic residues in
fish with a detection limit of 0.01 µg/mL (9). Hilton and
co-workers (10) used HPLC-electrospray MS in combination with solid phase extraction (SPE) for the detection
of several antibiotics contaminated in water including
erythromycin. Flurer et al.(11) proposed micellar eletro-
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Figure 1. Structure of erythromycin stearate.
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kinetic chromatography (MEKC) for the determination
of β-lactam antibiotics, aminoglycoside, clindamycin
phosphate and erythromycin stearate using borate buffer
containing sodium dodecyl sulfate as a background electrolyte. Spectrof luorometry (12) and spectrophotometry
using complex formation(13-14) were also proposed for the
analysis of erythromycin in formulations.
The United States Pharmacopoeia (USP)(15) and the
British Pharmacopoeia (BP) (16) recommend an HPLC
method and microbial assay for the analysis of erythromycin content in raw material and finished products,
respectively. Although HPLC is suggested, the technique
requires highly skillful operator and the instrument is
expensive and not available for most local manufacturers.
Whereas, the microbial assay is time-consuming. The
aim of this work was to develop a simple and rapid spectrophotometric method for the analysis of erythromycin
in pharmaceutical preparations. Both the direct ultraviolet (UV) and first derivative (D1) measurements with
external standard (ESM) and standard addition methods
(SAM) were performed. The D1 measurement using the
standard addition method was investigated to evaluate
whether matrices from tablets would interfere the analysis. The proposed method can be applicable to various
laboratories because of its simplicity, low cost and the
availability of the spectrophotometer, which is common
to most manufacturers. The method serves as an alternative to the methods described in pharmacopoeias.

MATERIALS AND METHODS
I. Chemicals
Analytical grade reagents and solvents were used
in all experiments. Standard erythromycin stearate was
purchased from Sun Pharma (Mumbai, India), dibasic
potassium phosphate was from Hopkin & Williams
(London, England) and phosphoric acid was from BDH
Lab (Dorest, England). Erythromycin stearate tablets
(brand A) and capsules (brand B) (equivalent to 250 mg
erythromycin per tablet or capsule) were from SeaPharm
Manufacturing (Ayudhaya, Thailand) and from a local
drugstore, respectively. Water was double distilled.
Standard solutions were prepared by dissolving
appropriate amount of erythromycin stearate in methanol
and dibasic phosphate buffer pH 8.0 (1:1) to obtain the
final concentrations of 3, 6, 9, 12 and 15 mg/mL.
Twenty tablets of brand A were weighed, finely
ground and mixed. In case of brand B, powder from 20
capsules was emptied from the shells and mixed. Sample
solutions were prepared in triplicate by weighing appropriate amount of erythromycin, dissolving in methanol
and dibasic phosphate buffer pH 8.0 (1:1) to obtain the
final concentration of 12 mg/mL (for ESM experiments),
and filtering through a Whatman paper no. 1
Standard addition solutions were prepared by trans-

ferring 10 mL of various standard solutions (3, 6, 9, 12
and 15 mg/mL), adding 5 mL of sample solutions (20 and
25 mg/mL for brands A and B, respectively) and adjusting to 25 mL with methanol and dibasic phosphate buffer
pH 8.0 (1:1). Standard addition solutions were prepared
as described in Table 1.
II. Instrumentation
The pH measu rements were car r ied out with a
Consort C830 pH meter equipped with a glass combined
electrode (Turnhout, Belgium). UV absorbance and spectra were obtained from a UV-160A Shidmadzu spectrophotometer (Kyoto, Japan). The direct UV and D1 measurements were performed at 285 and 300 nm, respectively.
III. Analytical Performance Characteristics
Analytical performance characteristics including
linearity, precision, accuracy, limit of detection (LOD)
and limit of quantitation (LOQ) for the analysis of erythromycin by spectrophotometry using direct UV and D1
measurements were evaluated. Standard curves were
obtained by measurement the absorbance of the standard
solutions of erythromycin in a range of 3-15 mg/mL for
ESM and in a range of 25-120% of the nominal concentration (5 mg/mL) for SAM. Linear regression and correlation coefficient (r 2) were calculated using Microsoft
Excel® program. Precision of the method was determined
by repetitive measurements (n = 3) of the absorbance of
standard solutions at the top, middle and bottom points
of the standard curve and percent relative standard deviations (%RSDs) were calculated. Recoveries (%R) of
the method were determined from SAM by spiking five
different concentrations of standard solutions in a range of
25-120% of the nominal sample concentration (5 mg/mL)
into the sample solutions as described in Table 1. Recovery experiments were performed in triplicate for both
brands A and B and %R was calculated using Eq (1).
amount found
(1)
%R =
× 100
amount added
LOD and LOQ are defined as the lowest amount that
can be detected and that can be accurately quantified,

Table 1. Standard addition solutions
Flask no.

1

2

3

4

5

6

Std. 3 mg/mL (mL)

10

-

-

-

-

-

Std. 6 mg/mL (mL)

-

10

-

-

-

-

Std. 9 mg/mL (mL)

-

-

10

-

-

-

Std. 12 mg/mL (mL)

-

-

-

10

-

-

Std. 15 mg/mL (mL)

-

-

-

-

10

-

Sample (mL)

5

5

5

5

5

5

Methanol: buffer pH 8.0
(1:1) q.s. to (mL)

25

25

25

25

25

25
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respectively. LOD and LOQ were calculated using Eq (2)
and (3), respectively, where SD is the standard deviation
of the blank and S is the slope of the standard curve.
3.3 SD
LOD =
(2)
S
10 SD
S

(3)

Abs

LOD =

1.000

0.500

RESULTS AND DISCUSSION
I. Direct and UV D1 Measurements Using External
Standard Method
Standard erythromycin solutions gave typical direct
UV and D1 spectra in methanol and dibasic phosphate
buffer pH 8.0 (1:1) as shown in Figures 2 and 3, respectively. The maximum direct UV absorbance of erythromycin was obtained at the wavelength of 285 nm and
the D1 absorption was measured at 300 nm. Preliminary
experiments, using ESM, showed that both measurements provided good linearity (r 2 > 0.999, in a range of
3-15 mg/mL) and good precision (%RSD < 1.79%). Both
techniques were initially used for assay of erythromycin
content in brands A and B (Table 2). The high %label
amount (120-154%, %RSD = 3.47-6.03%) with varied
and low % recovery indicated that matrices in samples
might interfere with the measurements and SAM should
be employed to overcome this problem. Thus, the direct
UV and D1 measurements in combination with SAM
were further investigated in both brands A and B for the
remaining of the study.
II. Analytical Performance Characteristics of Direct UV
and D1 Measurements Using Standard Addition Method
For the standard addition experiments, sample soultions of brand A and B were prepared at 20 and 25 mg/
mL, respectively, and 5 mL of these solutions was added
into the standard solution as described in MATERIALS
AND METHODS. The total concentration in the standard
addition experiments provided reasonable absorbencies
in a range of 0.5-0.7. Brand A was prepared at the lower
concentration (20 mg/mL) and than brand B (25 mg/mL)
in the standard addition experiments, since matrices in
brand A interfered with the UV absorption and gave the
absorbance, which was out of the linearity range.
Spect rophotomet r ic character istics in ter ms of
absorptivity and Sandell’s sensitivity are presented in
Table 3. For both the direct UV and D1 measurements,
the absorptivity and Sandell’s sensitivity values from
brand A and B were similar. It is evident that the direct
UV measurement was approximately 20 times more
sensitive than the D1 measurement. The molar absorptivity of the direct UV measurement was higher than that
from the D1 measurement, whereas the Sandell’s sensi-

0.000
200.0

300.0

400.0

Wavelength (nm)

Figure 2. Typical direct UV spectra of various concentration of
standard erythromycin solutions from 3 (bottom) 6, 9, 12 and 15
(top) mg/mL in methanol and dibasic phosphate buffer pH 8.0 (1:1).
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Figure 3. A typical first derivative measurement spectrum of a
standard erythromycin solution (12 mg/mL in methanol and dibasic
phosphate buffer pH 8.0 (1:1).

Table 2. Assay data (% label amount) from the direct UV and
D1 measurements using external standard and standard addition
methods (n = 3)
Direct UV

a

D1

ESMa

SAM b

ESM

SAM

Brand A

154.13

154.61

139.08

134.98

Brand B

126.19

137.02

120.19

99.85

ESM = external standard method.
SAM = standard addition method.

b

Table 3. Molar absorptivity (ε) and Sandell’s sensitivity (s) data
Direct UV

D1
2

ε (L/mol cm) s (mg/cm ) ε (L/mol cm) s (mg/cm2)
Brand A

37.43

0.020

1.89

0.389

Brand B

44.03

0.017

1.98

0.373
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tivity values were vice versa. This data indicated that
the direct UV measurement was more sensitive than the
D1 measurement i.e. the small change in concentration
caused a large change in the direct UV measurement, but
only a small change in the D1 measurement. This remark
was later confirmed by the slope of the linear regression,
LOD and LOQ.
The linearity, precision, LOD and LOQ data of the
direct UV and D1 measurements using SAM was shown
in Table 4. Both direct UV and D1 measurements gave
good linearity (r 2 > 0.98), precision (%RSD < 0.65%)
with acceptable LOD (0.236 mg/mL) and LOQ (4.17
mg/mL) for a spectrophotometric method. Slopes from
the direct UV measurement were approximately 16-18
times higher than those of D1 measurement, which indicated that the former method was more sensitive than
the latter. This data was also in agreement with the
absorptivity, Sandell’s sensitivity (Table 3), LOD and
LOQ values (Table 4). Recoveries of the methods for
brands A and B were shown in Table 5. The recovery
data from the direct UV measurement revealed very poor
and varied %recoveries (14.89-81.60%) with high %RSD
(up to 47.39%). Although SAM was used, the low recoveries were found in case of direct UV measurement.
These results indicated that the direct UV measurement
was not suitable for the analysis of erythromycin in

these samples. Whereas, D1 measurements offered good
recoveries within 94.92-109.32% with the %RSD of less
than 3.34%. We reasoned that matrices from samples
might interfere with the direct UV absorption of erythromycin in the samples. In order to completely eliminate the matrix effect, the D1 measurement with SAM
is recommended. These results strongly indicated that
D1 measurement was superior to the direct UV measurement in term of accuracy.
III. Applications
Table 2 compares the assay data from direct UV and
D1 measurements using ESM and SAM. The analytical perfor mance characteristic data from the previous section indicated that the D1 measurement with
SAM provided more reliable results than the direct UV
measurement. This conclusion was made based on
the analytical performance characteristic data in Table
4 and 5. D1 measurement with SAM provided better
linearity precision and accuracy than direct UV. Thus,
the D1 measurement with SAM was employed to evaluate the erythromycin content in the samples. In the
current work, one sample complied with the USP standard (90.0-120.0%), whereas the other failed to meet the
requirement (Table 2).

Table 4. Linearity, precision, LOD and LOQ of the direct UV and D1 measurements using standard addition method
Linearity

Brand A
Brand B

Precision (%RSD)

LOD

LOQ

(n = 3)

(mg/mL)

(mg/mL)

Direct UV

D1

Direct UV

D1

Direct UV

D1

Direct UV

D1

y = 0.0434x + 0.2736

y = 0.0024x + 0.0132

0.48

0.00

0.076

1.37

0.230

4.17

(r 2 = 0.9892)

(r 2 = 0.9967)

y = 0.0424x + 0.2843

y = 0.0026x + 0.0127

0.65

0.00

0.078

1.27

0.236

3.85

2

(r = 0.9836)

2

(r = 0.9917)

Table 5. Recovery data of the direct UV and D1 measurements using standard addition method
Brand A

Brand B

Direct UV

D1
%R

Amount

Direct UV
%R

Amount

Amount

added (mg/mL)

found (mg/mL)

1.18

0.40

33.90

1.12

94.92

0.46

38.98

1.29

109.32

2.35

1.45

61.70

2.32

98.72

0.35

14.89

2.54

108.09

3.53

2.59

73.37

3.52

99.72

1.32

37.39

3.80

107.65

4.7

3.74

79.57

4.72

100.43

2.89

61.49

5.05

107.45

5.87

4.79

81.60

5.52

94.04

3.89

66.27

5.89

100.34

found (mg/mL)

Amount

D1
%R

found (mg/mL)

Amount

%R

found (mg/mL)

Average

66.03

97.56

43.80

106.57

SD

19.56

2.90

20.75

3.56

%RSD

29.63

2.97

47.39

3.34
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CONCLUSIONS
A spectrophotometric method, without the use of
complex formation or derivatization, for the determination of erythromycin in dosage forms was developed.
Erythromycin can be determined by direct measuring
the absorbances at the wavelength of 285 nm or by first
derivative measurement at the wavelength of 300 nm
using standard addition method. Both methods provided
good linearity, precision, LOD and LOQ. However, the
D1 measurement showed superior recoveries to the direct
UV measurement. The standard addition method was
also required for the analysis of erythromycin in samples
in order to minimize the interference from matrices.
Thus, the first derivative measurement using the standard addition method was recommended for the analysis
of erythromycin in dosage forms. Unlike other researchers, which reported the use of advanced techniques (e.g.
HPLC, HPTLC and CE), we described a simple spectrophotometric method for the determination of erythromycin. The proposed method will not replace the methods
recommended in USP or BP or other published methods.
But, it will serve as a rapid, convenient and inexpensive
alternative, which can be applicable for most routine
quality control in laboratories.
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